Embrace Multiproducts Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.50 Cr
- Revenue Growth 19.52%
- Profit Growth 5.78%
- Ebitda -9.94%
- Net Worth 44.24%
- Total Assets 23.58%
About Embrace Multiproducts
Embrace Multiproducts Private Limited (EMPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 02 January 2012 and has a history of 13 years and one month. Its registered office is in Delhi, India.
The Corporate was formerly known as Maa Durga Multiproducts Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.50 Cr.
Anu Gupta and Rakesh Kumar serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U35990DL2012PTC229543
-
Company No.
229543
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 Jan 2012
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Embrace Multiproducts?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anu Gupta
|
Director | 19-Oct-2016 | Current |
|
Rakesh Kumar
|
Director | 19-Oct-2016 | Current |
Financial Performance of Embrace Multiproducts.
Embrace Multiproducts Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 19.52% increase. The company also saw a slight improvement in profitability, with a 5.78% increase in profit. The company's net worth Soared by an impressive increase of 44.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Embrace Multiproducts?
In 2021, Embrace Multiproducts had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Vanshita Nutraceuticals Private LimitedAnu Gupta and Rakesh Kumar are mutual person
-
Sandoz Biologics Llp
Anu Gupta is a mutual person
-
Dee Pharma And Foods Private Limited
Anu Gupta is a mutual person
Charges (Loans)
₹15.00 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 1.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Mar 2022 | Axis Bank Limited | ₹1.50 Cr | Open |
How Many Employees Work at Embrace Multiproducts?
Unlock and access historical data on people associated with Embrace Multiproducts, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Embrace Multiproducts, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Embrace Multiproducts's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
